Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P95
Near historical high
vs 2Y Ago
8.9x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 35.89% |
| Q3 2025 | 19.26% |
| Q2 2025 | -3.79% |
| Q1 2025 | -13.97% |
| Q4 2024 | 0.57% |
| Q3 2024 | -0.65% |
| Q2 2024 | -17.65% |
| Q1 2024 | -7.22% |
| Q4 2023 | 4.05% |
| Q3 2023 | 12.73% |
| Q2 2023 | 0.65% |
| Q1 2023 | -29.04% |
| Q4 2022 | -1.47% |
| Q3 2022 | 17.93% |
| Q2 2022 | 5.00% |
| Q1 2022 | -16.43% |
| Q4 2021 | -36.58% |
| Q3 2021 | -2.31% |
| Q2 2021 | -30.47% |
| Q1 2021 | 21.50% |
| Q4 2020 | -46.70% |
| Q3 2020 | -9.04% |
| Q2 2020 | -0.86% |
| Q1 2020 | 3.62% |
| Q4 2019 | -2.44% |
| Q3 2019 | -0.40% |
| Q2 2019 | -5.63% |
| Q1 2019 | 6.11% |
| Q4 2018 | -10.33% |
| Q3 2018 | -0.60% |
| Q2 2018 | 21.71% |
| Q1 2018 | -86.23% |
| Q4 2017 | 40.12% |
| Q3 2017 | 46.66% |
| Q2 2017 | 19.54% |
| Q1 2017 | -16.98% |
| Q4 2016 | 16.12% |
| Q3 2016 | 0.11% |
| Q2 2016 | 0.59% |
| Q1 2016 | -39.04% |